KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Enterprise Value (2016 - 2026)

Edwards Lifesciences has reported Enterprise Value over the past 17 years, most recently at -$4.2 billion for Q4 2025.

  • For Q4 2025, Enterprise Value fell 8.05% year-over-year to -$4.2 billion; the TTM value through Dec 2025 reached -$4.2 billion, down 8.05%, while the annual FY2025 figure was -$4.2 billion, 8.05% down from the prior year.
  • Enterprise Value for Q4 2025 was -$4.2 billion at Edwards Lifesciences, down from -$3.8 billion in the prior quarter.
  • Over five years, Enterprise Value peaked at -$442.8 million in Q4 2023 and troughed at -$4.4 billion in Q3 2024.
  • A 5-year average of -$2.2 billion and a median of -$1.7 billion in 2022 define the central range for Enterprise Value.
  • Biggest five-year swings in Enterprise Value: skyrocketed 63.34% in 2023 and later crashed 783.33% in 2024.
  • Year by year, Enterprise Value stood at -$1.5 billion in 2021, then rose by 17.66% to -$1.2 billion in 2022, then surged by 63.34% to -$442.8 million in 2023, then tumbled by 783.33% to -$3.9 billion in 2024, then dropped by 8.05% to -$4.2 billion in 2025.
  • Business Quant data shows Enterprise Value for EW at -$4.2 billion in Q4 2025, -$3.8 billion in Q3 2025, and -$4.0 billion in Q2 2025.